Prognostic Value of Subclinical Coronary Artery Disease in Atrial Fibrillation Patients Identified by Coronary Computed Tomography Angiography
Identifying coronary artery disease (CAD) in atrial fibrillation (AF) patients improves risk stratification and defines clinical management. However, the value of screening for subclinical CAD with cardiac CT in AF patients is unknown. Between 2011 and 2015, 94 consecutive patients without known or...
Gespeichert in:
| Veröffentlicht in: | The American journal of cardiology 2020-07, Vol.126, p.16-22 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 22 |
|---|---|
| container_issue | |
| container_start_page | 16 |
| container_title | The American journal of cardiology |
| container_volume | 126 |
| creator | Nous, Fay M.A. Budde, Ricardo P.J. van Dijkman, Eva D. Musters, Paul J. Nieman, Koen Galema, Tjebbe W. |
| description | Identifying coronary artery disease (CAD) in atrial fibrillation (AF) patients improves risk stratification and defines clinical management. However, the value of screening for subclinical CAD with cardiac CT in AF patients is unknown. Between 2011 and 2015, 94 consecutive patients without known or suspected CAD (66 (57–73) years, 68% male), who were referred for AF evaluation, underwent a noncontrast-enhanced coronary calcium scan and a coronary computed tomography angiography (CCTA) at our center. We retrospectively evaluated the coronary calcium score, the prevalence of obstructive CAD (≥50% stenosis) determined by CCTA, compared clinical management and 5-year outcome in patients with and without obstructive CAD on CCTA, and examined the potential impact of a coronary calcium score and obstructive CAD on CCTA as a manifestation of vascular disease on the CHA2Ds2VASc score and for the cardiovascular risk stratification of AF patients. The median coronary calcium score was 57 (0–275) and 24 patients (26%) had obstructive CAD on CCTA. At baseline, patients with obstructive CAD more often used statins than those without obstructive CAD (54% vs 26%, p = 0.011). After a median clinical follow-up of 2.4 (0.5–4.5) years, patients with obstructive CAD more frequently used oral anticoagulant and/or antiplatelet drugs, statins, angiotensin-II-receptor blockers and/or angiotensin-converting-enzyme inhibitors, and less often used class I antiarrhythmic drugs than patients without obstructive CAD (all p |
| doi_str_mv | 10.1016/j.amjcard.2020.03.050 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2396309170</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914920303398</els_id><sourcerecordid>2396309170</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-c109e196cf12cf982380ca29512777c0b29e5b987d4396e337dfa53c872dd2103</originalsourceid><addsrcrecordid>eNqFkd-K1DAUxoMo7rj6CErAG29a86dtmisZZl1dWHDB1duQJqdjSpuMSSrsS_jMZphRwRuvviT8zndyzofQS0pqSmj3dqr1Mhkdbc0IIzXhNWnJI7ShvZAVlZQ_RhtCCKskbeQFepbSVK6Utt1TdMEZb9pGsA36eRfD3oeUncFf9bwCDiP-vA5mdt4ZPeNdiMHr-IC3MUORK5dAJ8DO422OrhDXbohunnV2weO7IuBzwje2iBsdWDw8_HXZheWw5vJ4H5awj_rwrTj7vTufn6Mno54TvDjrJfpy_f5-97G6_fThZre9rUzTkFwZSiRQ2ZmRMjPKnvGeGM1kS5kQwpCBSWgH2QvbcNkB58KOuuWmF8xaRgm_RG9OvocYvq-QslpcMlCm8BDWpFgp40RScURf_4NOYY2-_E6xhrVdT_tOFKo9USaGlCKM6hDdUiZWlKhjYGpS58DUMTBFuCqBlbpXZ_d1WMD-qfqdUAHenQAo6_jhIKpkyoYNWBfBZGWD-0-LXy1VqpA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2425681867</pqid></control><display><type>article</type><title>Prognostic Value of Subclinical Coronary Artery Disease in Atrial Fibrillation Patients Identified by Coronary Computed Tomography Angiography</title><source>ScienceDirect</source><source>ProQuest Central UK/Ireland</source><creator>Nous, Fay M.A. ; Budde, Ricardo P.J. ; van Dijkman, Eva D. ; Musters, Paul J. ; Nieman, Koen ; Galema, Tjebbe W.</creator><creatorcontrib>Nous, Fay M.A. ; Budde, Ricardo P.J. ; van Dijkman, Eva D. ; Musters, Paul J. ; Nieman, Koen ; Galema, Tjebbe W.</creatorcontrib><description>Identifying coronary artery disease (CAD) in atrial fibrillation (AF) patients improves risk stratification and defines clinical management. However, the value of screening for subclinical CAD with cardiac CT in AF patients is unknown. Between 2011 and 2015, 94 consecutive patients without known or suspected CAD (66 (57–73) years, 68% male), who were referred for AF evaluation, underwent a noncontrast-enhanced coronary calcium scan and a coronary computed tomography angiography (CCTA) at our center. We retrospectively evaluated the coronary calcium score, the prevalence of obstructive CAD (≥50% stenosis) determined by CCTA, compared clinical management and 5-year outcome in patients with and without obstructive CAD on CCTA, and examined the potential impact of a coronary calcium score and obstructive CAD on CCTA as a manifestation of vascular disease on the CHA2Ds2VASc score and for the cardiovascular risk stratification of AF patients. The median coronary calcium score was 57 (0–275) and 24 patients (26%) had obstructive CAD on CCTA. At baseline, patients with obstructive CAD more often used statins than those without obstructive CAD (54% vs 26%, p = 0.011). After a median clinical follow-up of 2.4 (0.5–4.5) years, patients with obstructive CAD more frequently used oral anticoagulant and/or antiplatelet drugs, statins, angiotensin-II-receptor blockers and/or angiotensin-converting-enzyme inhibitors, and less often used class I antiarrhythmic drugs than patients without obstructive CAD (all p <0.050). After a median follow-up of 5.7 (4.8–6.8) years, mortality was higher in patients with obstructive CAD than in those without obstructive CAD (29% vs 11%, log-rank test: p = 0.034). Implementation of a coronary calcium score and/or obstructive CAD on CCTA elevated the CHA2Ds2VASc score and cardiovascular risk stratification in 42 patients (p <0.001) and 47 patients (p = 0.006), respectively. In conclusion, we observed a high prevalence of obstructive CAD on CCTA in AF patients without known or suspected CAD. AF patients with obstructive CAD were managed differently and had a worse prognosis than those without obstructive CAD. Cardiac CT could enhance cardiovascular risk stratification of AF patients.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2020.03.050</identifier><identifier>PMID: 32345472</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Angiography ; Angiotensin ; Angiotensin II ; Anticoagulants ; Arrhythmia ; Calcium ; Cardiac arrhythmia ; Cardiovascular disease ; Cardiovascular diseases ; Computed tomography ; Coronary artery ; Coronary artery disease ; Drugs ; Enzyme inhibitors ; Evaluation ; Fibrillation ; Health risk assessment ; Health risks ; Heart ; Heart diseases ; Medical imaging ; Mortality ; Peptidyl-dipeptidase A ; Rank tests ; Risk ; Risk management ; Statins ; Stenosis ; Stroke ; Tomography ; Vascular diseases</subject><ispartof>The American journal of cardiology, 2020-07, Vol.126, p.16-22</ispartof><rights>2020 The Author(s)</rights><rights>Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.</rights><rights>2020. The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-c109e196cf12cf982380ca29512777c0b29e5b987d4396e337dfa53c872dd2103</citedby><cites>FETCH-LOGICAL-c440t-c109e196cf12cf982380ca29512777c0b29e5b987d4396e337dfa53c872dd2103</cites><orcidid>0000-0003-3792-615X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2425681867?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974,64362,64364,64366,72216</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32345472$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nous, Fay M.A.</creatorcontrib><creatorcontrib>Budde, Ricardo P.J.</creatorcontrib><creatorcontrib>van Dijkman, Eva D.</creatorcontrib><creatorcontrib>Musters, Paul J.</creatorcontrib><creatorcontrib>Nieman, Koen</creatorcontrib><creatorcontrib>Galema, Tjebbe W.</creatorcontrib><title>Prognostic Value of Subclinical Coronary Artery Disease in Atrial Fibrillation Patients Identified by Coronary Computed Tomography Angiography</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Identifying coronary artery disease (CAD) in atrial fibrillation (AF) patients improves risk stratification and defines clinical management. However, the value of screening for subclinical CAD with cardiac CT in AF patients is unknown. Between 2011 and 2015, 94 consecutive patients without known or suspected CAD (66 (57–73) years, 68% male), who were referred for AF evaluation, underwent a noncontrast-enhanced coronary calcium scan and a coronary computed tomography angiography (CCTA) at our center. We retrospectively evaluated the coronary calcium score, the prevalence of obstructive CAD (≥50% stenosis) determined by CCTA, compared clinical management and 5-year outcome in patients with and without obstructive CAD on CCTA, and examined the potential impact of a coronary calcium score and obstructive CAD on CCTA as a manifestation of vascular disease on the CHA2Ds2VASc score and for the cardiovascular risk stratification of AF patients. The median coronary calcium score was 57 (0–275) and 24 patients (26%) had obstructive CAD on CCTA. At baseline, patients with obstructive CAD more often used statins than those without obstructive CAD (54% vs 26%, p = 0.011). After a median clinical follow-up of 2.4 (0.5–4.5) years, patients with obstructive CAD more frequently used oral anticoagulant and/or antiplatelet drugs, statins, angiotensin-II-receptor blockers and/or angiotensin-converting-enzyme inhibitors, and less often used class I antiarrhythmic drugs than patients without obstructive CAD (all p <0.050). After a median follow-up of 5.7 (4.8–6.8) years, mortality was higher in patients with obstructive CAD than in those without obstructive CAD (29% vs 11%, log-rank test: p = 0.034). Implementation of a coronary calcium score and/or obstructive CAD on CCTA elevated the CHA2Ds2VASc score and cardiovascular risk stratification in 42 patients (p <0.001) and 47 patients (p = 0.006), respectively. In conclusion, we observed a high prevalence of obstructive CAD on CCTA in AF patients without known or suspected CAD. AF patients with obstructive CAD were managed differently and had a worse prognosis than those without obstructive CAD. Cardiac CT could enhance cardiovascular risk stratification of AF patients.</description><subject>Angiography</subject><subject>Angiotensin</subject><subject>Angiotensin II</subject><subject>Anticoagulants</subject><subject>Arrhythmia</subject><subject>Calcium</subject><subject>Cardiac arrhythmia</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Computed tomography</subject><subject>Coronary artery</subject><subject>Coronary artery disease</subject><subject>Drugs</subject><subject>Enzyme inhibitors</subject><subject>Evaluation</subject><subject>Fibrillation</subject><subject>Health risk assessment</subject><subject>Health risks</subject><subject>Heart</subject><subject>Heart diseases</subject><subject>Medical imaging</subject><subject>Mortality</subject><subject>Peptidyl-dipeptidase A</subject><subject>Rank tests</subject><subject>Risk</subject><subject>Risk management</subject><subject>Statins</subject><subject>Stenosis</subject><subject>Stroke</subject><subject>Tomography</subject><subject>Vascular diseases</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkd-K1DAUxoMo7rj6CErAG29a86dtmisZZl1dWHDB1duQJqdjSpuMSSrsS_jMZphRwRuvviT8zndyzofQS0pqSmj3dqr1Mhkdbc0IIzXhNWnJI7ShvZAVlZQ_RhtCCKskbeQFepbSVK6Utt1TdMEZb9pGsA36eRfD3oeUncFf9bwCDiP-vA5mdt4ZPeNdiMHr-IC3MUORK5dAJ8DO422OrhDXbohunnV2weO7IuBzwje2iBsdWDw8_HXZheWw5vJ4H5awj_rwrTj7vTufn6Mno54TvDjrJfpy_f5-97G6_fThZre9rUzTkFwZSiRQ2ZmRMjPKnvGeGM1kS5kQwpCBSWgH2QvbcNkB58KOuuWmF8xaRgm_RG9OvocYvq-QslpcMlCm8BDWpFgp40RScURf_4NOYY2-_E6xhrVdT_tOFKo9USaGlCKM6hDdUiZWlKhjYGpS58DUMTBFuCqBlbpXZ_d1WMD-qfqdUAHenQAo6_jhIKpkyoYNWBfBZGWD-0-LXy1VqpA</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Nous, Fay M.A.</creator><creator>Budde, Ricardo P.J.</creator><creator>van Dijkman, Eva D.</creator><creator>Musters, Paul J.</creator><creator>Nieman, Koen</creator><creator>Galema, Tjebbe W.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3792-615X</orcidid></search><sort><creationdate>20200701</creationdate><title>Prognostic Value of Subclinical Coronary Artery Disease in Atrial Fibrillation Patients Identified by Coronary Computed Tomography Angiography</title><author>Nous, Fay M.A. ; Budde, Ricardo P.J. ; van Dijkman, Eva D. ; Musters, Paul J. ; Nieman, Koen ; Galema, Tjebbe W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-c109e196cf12cf982380ca29512777c0b29e5b987d4396e337dfa53c872dd2103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Angiography</topic><topic>Angiotensin</topic><topic>Angiotensin II</topic><topic>Anticoagulants</topic><topic>Arrhythmia</topic><topic>Calcium</topic><topic>Cardiac arrhythmia</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Computed tomography</topic><topic>Coronary artery</topic><topic>Coronary artery disease</topic><topic>Drugs</topic><topic>Enzyme inhibitors</topic><topic>Evaluation</topic><topic>Fibrillation</topic><topic>Health risk assessment</topic><topic>Health risks</topic><topic>Heart</topic><topic>Heart diseases</topic><topic>Medical imaging</topic><topic>Mortality</topic><topic>Peptidyl-dipeptidase A</topic><topic>Rank tests</topic><topic>Risk</topic><topic>Risk management</topic><topic>Statins</topic><topic>Stenosis</topic><topic>Stroke</topic><topic>Tomography</topic><topic>Vascular diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nous, Fay M.A.</creatorcontrib><creatorcontrib>Budde, Ricardo P.J.</creatorcontrib><creatorcontrib>van Dijkman, Eva D.</creatorcontrib><creatorcontrib>Musters, Paul J.</creatorcontrib><creatorcontrib>Nieman, Koen</creatorcontrib><creatorcontrib>Galema, Tjebbe W.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nous, Fay M.A.</au><au>Budde, Ricardo P.J.</au><au>van Dijkman, Eva D.</au><au>Musters, Paul J.</au><au>Nieman, Koen</au><au>Galema, Tjebbe W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic Value of Subclinical Coronary Artery Disease in Atrial Fibrillation Patients Identified by Coronary Computed Tomography Angiography</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>126</volume><spage>16</spage><epage>22</epage><pages>16-22</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><abstract>Identifying coronary artery disease (CAD) in atrial fibrillation (AF) patients improves risk stratification and defines clinical management. However, the value of screening for subclinical CAD with cardiac CT in AF patients is unknown. Between 2011 and 2015, 94 consecutive patients without known or suspected CAD (66 (57–73) years, 68% male), who were referred for AF evaluation, underwent a noncontrast-enhanced coronary calcium scan and a coronary computed tomography angiography (CCTA) at our center. We retrospectively evaluated the coronary calcium score, the prevalence of obstructive CAD (≥50% stenosis) determined by CCTA, compared clinical management and 5-year outcome in patients with and without obstructive CAD on CCTA, and examined the potential impact of a coronary calcium score and obstructive CAD on CCTA as a manifestation of vascular disease on the CHA2Ds2VASc score and for the cardiovascular risk stratification of AF patients. The median coronary calcium score was 57 (0–275) and 24 patients (26%) had obstructive CAD on CCTA. At baseline, patients with obstructive CAD more often used statins than those without obstructive CAD (54% vs 26%, p = 0.011). After a median clinical follow-up of 2.4 (0.5–4.5) years, patients with obstructive CAD more frequently used oral anticoagulant and/or antiplatelet drugs, statins, angiotensin-II-receptor blockers and/or angiotensin-converting-enzyme inhibitors, and less often used class I antiarrhythmic drugs than patients without obstructive CAD (all p <0.050). After a median follow-up of 5.7 (4.8–6.8) years, mortality was higher in patients with obstructive CAD than in those without obstructive CAD (29% vs 11%, log-rank test: p = 0.034). Implementation of a coronary calcium score and/or obstructive CAD on CCTA elevated the CHA2Ds2VASc score and cardiovascular risk stratification in 42 patients (p <0.001) and 47 patients (p = 0.006), respectively. In conclusion, we observed a high prevalence of obstructive CAD on CCTA in AF patients without known or suspected CAD. AF patients with obstructive CAD were managed differently and had a worse prognosis than those without obstructive CAD. Cardiac CT could enhance cardiovascular risk stratification of AF patients.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32345472</pmid><doi>10.1016/j.amjcard.2020.03.050</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-3792-615X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9149 |
| ispartof | The American journal of cardiology, 2020-07, Vol.126, p.16-22 |
| issn | 0002-9149 1879-1913 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2396309170 |
| source | ScienceDirect; ProQuest Central UK/Ireland |
| subjects | Angiography Angiotensin Angiotensin II Anticoagulants Arrhythmia Calcium Cardiac arrhythmia Cardiovascular disease Cardiovascular diseases Computed tomography Coronary artery Coronary artery disease Drugs Enzyme inhibitors Evaluation Fibrillation Health risk assessment Health risks Heart Heart diseases Medical imaging Mortality Peptidyl-dipeptidase A Rank tests Risk Risk management Statins Stenosis Stroke Tomography Vascular diseases |
| title | Prognostic Value of Subclinical Coronary Artery Disease in Atrial Fibrillation Patients Identified by Coronary Computed Tomography Angiography |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T17%3A32%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20Value%20of%20Subclinical%20Coronary%20Artery%20Disease%20in%20Atrial%20Fibrillation%20Patients%20Identified%20by%20Coronary%20Computed%20Tomography%20Angiography&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Nous,%20Fay%20M.A.&rft.date=2020-07-01&rft.volume=126&rft.spage=16&rft.epage=22&rft.pages=16-22&rft.issn=0002-9149&rft.eissn=1879-1913&rft_id=info:doi/10.1016/j.amjcard.2020.03.050&rft_dat=%3Cproquest_cross%3E2396309170%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2425681867&rft_id=info:pmid/32345472&rft_els_id=S0002914920303398&rfr_iscdi=true |